Alterity Therapeutics (ATHE) Other Accumulated Expenses (2019 - 2025)

Alterity Therapeutics has reported Other Accumulated Expenses for 7 years, with the latest figure at $89.29 in Q4 2025.

• For the quarter ending Q4 2025, Other Accumulated Expenses fell 7.11% year-over-year to $89.29; the trailing twelve-month figure through Dec 2025 stood at $89.29 (down 7.11% YoY), and the FY2025 full-year result was $89.02, down 99.86% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $89.29, roughly flat from $89.02 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $116587.2 in Q4 2023, with the low at -$189.88 in Q4 2022.
• Average Other Accumulated Expenses over 5 years is $27859.0, with a median of $6024.6 recorded in 2021.
• Year-over-year, Other Accumulated Expenses tumbled 101.72% in 2022 and surged 61500.68% in 2023.
• Tracing ATHE's Other Accumulated Expenses over 5 years: stood at $11049.2 in 2021, then tumbled by 101.72% to -$189.88 in 2022, then surged by 61500.68% to $116587.2 in 2023, then sank by 99.92% to $96.13 in 2024, then dropped by 7.11% to $89.29 in 2025.
• The last three Other Accumulated Expenses figures came in at $89.29 (Q4 2025), $89.02 (Q2 2025), and $96.13 (Q4 2024), per Business Quant data.

Peer Comparison